PAVmed (PAVM) Short-term Investments (2024 - 2025)

PAVmed's (PAVM) quarterly Short-term Investments came in at $299000.0 in Q3 2025, little changed quarter-over-quarter from $299000.0 in Q2 2025.

PAVmed (PAVM) Short-term Investments (2024 - 2025) Analysis & Trends

PAVmed's Short-term Investments history runs 2 years deep, the most recent figure standing at $299000.0 for Q3 2025.

On a quarterly basis, Short-term Investments changed N/A year-over-year to $299000.0 in Q3 2025; TTM through Sep 2025 was $299000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $299000.0, changed N/A from the prior year.
Short-term Investments was little changed at $299000.0 in Q3 2025 per PAVM's latest filing, from $299000.0 in the prior quarter.
Across five years, Short-term Investments topped out at $299000.0 in Q4 2024 and bottomed at $299000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	PAVmed	9.85 Mn	-3.35 Mn	-4,000.00

Download Data